U.S. issued AgriMetis’s L-Glufosinate process patent
Dec. 8, 2017
The patent claims are drawn to a two-step process for the production of substantially pure L-Glufosinate. This novel enzymatic process substantially increases the proportion of the active L-Glufosinate isomer in the mixture with D-Glufosinate.
Glu-L is an improved alternative to the commercial racemic glufosinate being manufactured and sold. The milestone achievement described in this patent exemplifies how the AgriMetis approach of combining biology and chemistry can lead to differentiated active ingredients in a well-studied agricultural crop protection market.
“We are especially proud of this important development as it will provide farmers the potential for more efficient and improved products for broad spectrum weed control,” said Steven Tuttle, President and CEO of AgriMetis.
More from AgroNews
- Higher tier testing would answer neonicotinoid pesticide question
- Top 20 Brazilian agrochem companies in 2017: Mergers will increase market concentration in the future
- Sichuan Lomon Bio Takes S-ABA and Gibberellin as Core Products to Build Full Range Product Line on Basis of Biotechnology
- AkzoNobel Specialty Chemicals rebrands as Nouryon